The authors report that PKHD1L1 is expressed in human reproductive epithelium and that its expression is estrogen-responsive. Specifically, expression was demonstrated in the epithelial cells of the endometrium and the Fallopian tube, tissues directly relevant to conception and early embryo transport. These findings place PKHD1L1 within a hormonal and tissue context plausibly connected to female reproductive function.
The work characterizes a relatively common splice donor variant, rs17368310, affecting the PKHD1L1 gene. In endometrial tissue, the authors identified a change in the mRNA sequence associated with rs17368310, consistent with altered splicing at the transcript level in a reproductive tissue. The manuscript reports this molecular alteration in endometrial samples, supporting a tissue-specific transcriptomic consequence of the variant.
To assess potential consequences beyond the transcript, the authors used structural modeling to evaluate possible effects of rs17368310 on the PKHD1L1 protein. The modeling was presented as an approach to infer how the splice donor variant might alter protein structure or function. The source describes these modeling efforts as part of a mechanistic evaluation linking the genetic variant to protein-level changes, though full modeling details are provided in the primary manuscript.
Using population-scale data from Finland, the study assessed reproductive outcomes by genotype. Women homozygous for rs17368310 were reported to have a persistently lower child count compared with women carrying other genotypes. This reduction in observed number of children persisted not only across all women in the Finnish dataset but also within the subgroup of women who had undergone medical treatments for infertility. These population-level associations connect the molecular and tissue-level observations to a measurable reproductive phenotype in a national cohort.
The authors examined associations of rs17368310 with female infertility–related traits in a Mexican population cohort and reported that the variant also associated with infertility-related traits there. The presence of associations in both Finnish and Mexican populations supports the idea that rs17368310 may influence fertility across different ancestries and reproductive-age populations.
The study involved human tissue collection and analysis and used large-scale biobank and population data. Ethical approvals and participant consents were obtained from multiple institutional review boards and national agencies. Specific approvals cited include regional and institutional ethics committees for endometrial and Fallopian tube tissue collection and oversight approvals for the FinnGen study and the Mexico City Prospective Study. The authors state that all relevant ethical guidelines were followed and that participant consent forms and appropriate registrations are in place.
Data produced in the study are reported to be contained in the manuscript. Funding and support for the work are listed from several sources, including the University of Oulu, Research Council of Finland, Sigrid Jusélius Foundation, Fulbright Finland Foundation, Novo Nordisk Foundation, Business Finland, industry partners of FinnGen, Mexican Health Ministry and national science bodies, Wellcome, Cancer Research UK, the British Heart Foundation, Kidney Research UK, and the UK Medical Research Council, among others named in the source.
Taken together, the reported findings link a specific splice donor variant, rs17368310, in PKHD1L1 to molecular changes in endometrial mRNA, predicted impacts at the protein level via structural modeling, and measurable reproductive outcomes in population cohorts. The detection of estrogen-responsive expression in the endometrium and Fallopian tube provides a plausible biological context for how altered PKHD1L1 splicing might influence fertility.
The observation that homozygosity for rs17368310 associates with a lower child count in Finland, including among women treated for infertility, and that infertility-related trait associations were also seen in Mexico, suggests that the variant could affect reproductive success across populations. The authors emphasize the relevance of these findings to millions of reproductive-age women given the variant’s reported global frequency.
The summary above reflects the results and descriptions provided in the source manuscript. Where the source provides specific experimental or modeling details, those are reported in the manuscript itself; additional experimental parameters, quantitative effect sizes, or modeling metrics beyond what is described in the source were not reproduced here because they were not fully detailed in the summary text. Readers should consult the full manuscript and supplementary material for complete methods, statistical estimates, and modeling data.
This study characterizes a link between the PKHD1L1 splice donor variant rs17368310 and female reproductive biology and outcomes. Evidence spans hormone-responsive expression in reproductive epithelia, transcript-level alterations in endometrium, structural modeling of potential protein impacts, and consistent population associations with lower child count and infertility-related traits in Finnish and Mexican cohorts. The authors conclude that rs17368310 affects fertility in reproductive-age women across different populations.